Table 4 Imaging and medications os patients regarding access to care, by referral status
| Referred (N = 70) | Not Referred (N = 79) | P-value | |
|---|---|---|---|
| Number of patients with additional cardiac imaging | |||
| MUGA scan | 7 | 16 | p = 0.11 |
| Cardiac CT/MRI | 4 | 2 | p = 0.42 |
| Stress test | 11 | 7 | p = 0.22 |
| RHC | 2 | 4 | p = 0.68 |
| LHC | 1 | 7 | p = 0.07 |
| Medication post-chemo | |||
| Beta blocker | 54 | 24 | p < 0.0001 |
| ACEI/ARB | 50 | 26 | p < 0.0001 |
| Diuretic | 22 | 18 | p = 0.23 |
| CCB | 14 | 18 | p = 0.68 |
| Hydralazine | 6 | 1 | p = 0.035 |
| Nitrate | 4 | 1 | p = 0.13 |
| MRA | 7 | 1 | p = 0.018 |
| Antiarrhythmic | 2 | 0 | p = 0.49 |
| Aspirin | 24 | 20 | p = 0.23 |
| Statin | 32 | 22 | p = 0.024 |